Panel asks CDSCO to scrutinize report on adverse reaction of HCQ Farhat Nasim28 Oct 2020 12:22 PM GMTNew Delhi: Popular antimalarial drug Hydroxychloroquine (HCQ) has come under intense scrutiny over reports of adverse reaction of the drug, particularl...
Govt excludes anti-parasitic drug Ivermectin from Covid-19 treatment protocol ruchika25 Oct 2020 4:00 AM GMTA government official said, 'It has been decided not to recommend ivermectin medicine in the National Clinical Management Protocol for Covid19 as...
Medical equipment supply to be terminated from October: Centre to Maha Govt ruchika31 Aug 2020 5:39 AM GMTThe medical equipment which the Union government provided included PPE Kits,RT-PCR Kits, ventilators, N-95 masks, HCQ and other medicines and oxygen...
COVID-19 Battle: Govt removes export ban on anti-malarial drug HCQ ruchika19 Jun 2020 9:16 AM GMT'The export policy of Hydroxychloroquine API (active pharmaceutical ingredients) and its formulations from prohibited to free with immediate effect,'...
USFDA ends emergency use of hydroxychloroquine to treat Covid-19 MD Bureau15 Jun 2020 7:07 PM GMTThe drugs are traditionally used to treat malaria and certain autoimmune conditions, including lupus and rheumatoid arthritis. These can be taken to...
Govt shows green flag to HCQ for early COVID cases, remdesivir for moderate stage ruchika15 Jun 2020 10:09 AM GMTUnder emergency use authorization, remdesivir may be considered for patients in moderate stage requiring oxygen support.
Manufacturers to sell 20pc HCQ in domestic market, rest can be exported: Mansukh Mandaviya ruchika12 Jun 2020 9:16 AM GMT'When the COVID crisis started we had two units making Hydroxychloroquine, now we have 12 and production is more than the requirement. Hence, the...
Union Minister Piyush Goyal lauds Pharma Industry for rising during COVID crisis ruchika1 Jun 2020 12:38 PM GMTNew Delhi: The Commerce and Industry Minister Shri Piyush Goyal has interacted with the captains of the Pharmaceutical Industry, and Office-bearers of ...
COVID-19: HCQ can be used as preventive treatment, no side effects shown in Indian studies, says ICMR Medical Dialogues Bureau28 May 2020 9:29 AM GMTNew Delhi - No major side-effects of antimalarial drug Hydroxychloroquine (HCQ) have been found in studies in India and its use can be continued ...
WHO puts temporary pause on hydroxychloroquine clinical trial on COVID-19 patients MD Bureau26 May 2020 3:31 AM GMTA recent Lancet study reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate.
New Guideline: ICMR expands use of Hydroxychloroquine, adds ECG as prerequisite, Details MD Bureau23 May 2020 12:33 PM GMTNew Delhi: Expanding the use of anti-malarial drug hydroxychloroquine as a preventive treatment against coronavirus, the ICMR has issued new set of...
WHO warns against using hydroxychloroquine outside clinical trials MD Bureau21 May 2020 3:30 AM GMTGeneva: A senior official of the World Health Organization (WHO) has warned against using hydroxychloroquine or chloroquine, the drugs for malaria and ...
